AmerisourceBergen Corpora... (ABC)
NYSE: ABC
· Real-Time Price · USD
179.98
-0.41 (-0.23%)
At close: Aug 29, 2023, 10:00 PM
AmerisourceBergen Revenue Breakdown
| Period Ending | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | Sep 30, 2015 | Sep 30, 2014 | Sep 30, 2013 | Sep 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Distribution Revenue | 198.15B | 182.47B | 172.81B | 161.7B | 147.45B | 140.73B | 131.48B | 117.38B | 86.39B | 78.35B |
| Pharmaceutical Distribution Revenue Growth | +8.60% | +5.59% | +6.87% | +9.66% | +4.78% | +7.04% | +12.01% | +35.88% | +10.26% | n/a |
Revenue by Geography
| Period Ending | Sep 30, 2024 |
|---|---|
| International Healthcare Solutions Revenue | 28.63B |
| International Healthcare Solutions Revenue Growth | n/a |
| U.S. Healthcare Solutions Revenue | 265.34B |
| U.S. Healthcare Solutions Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.6B | 1.47B | 1.56B | 1.38B | 1.4B | 1.39B | 1.3B | 1.32B | 1.29B | 1.26B | 1.21B | 1.2B | 1.17B | 1.22B | 913.41M | 730.08M | 735.07M | 720.97M | 666.88M | 693.41M | 685.95M | 721.94M | 656.94M | 628.04M | 656.59M | 657.8M | 626.55M | 617.43M | 558.52M | 560.88M | 525.46M | 521.84M | 520.55M | 520.15M | 520.03M | 522.76M | 528.3M | 556.37M | 502.74M | 442.44M |
| Selling, General, and Administrative Revenue Growth | +8.69% | -5.90% | +13.10% | -1.11% | +0.35% | +6.88% | -1.28% | +2.34% | +2.17% | +4.23% | +0.74% | +2.83% | -3.75% | +33.09% | +25.11% | -0.68% | +1.96% | +8.11% | -3.83% | +1.09% | -4.99% | +9.89% | +4.60% | -4.35% | -0.19% | +4.99% | +1.48% | +10.55% | -0.42% | +6.74% | +0.69% | +0.25% | +0.08% | +0.02% | -0.52% | -1.05% | -5.05% | +10.67% | +13.63% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |